Skirball 20team 20pic
Screen 20shot 202017 06 06 20at 201.33.12 20pm

Thrombolex, Inc.

Interventional Catheter-Based Therapies for the Rapid and Effective Treatment of Acute Venous Thromboembolic Medical Disorders.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Doylestown, PA, US
  • Currency USD
  • Founded April 2016
  • Employees 4
  • Incorporation Type C-corp

Company Summary

Thrombolex, Inc. is focused on developing interventional catheter-based therapies for the rapid and effective treatment of acute venous thromboembolic medical disorders (VTE). The Company envisions a future series of unique catheters for the treatment of acute pulmonary embolism (PE), acute proximal deep vein thrombosis (DVT), including the inferior vena cava (IVC) filter complications.

Team

  • 6f07dcca 75b0 4245 934d 19a3279e6e88
    President & COO

    Co-founder of BlackRock Private Equity Partners (PEP), having served as Chairman of PEPs Investment Operating Committee. He leads the capital formation process while sharing the strategic management of the Company with Mr. Woodall.

  • Previously served as president of Johnson & Johnson's Interventional Systems, Inc. leading the team responsible for pioneering the transformational cardiovascular stent franchise. He served as the CEO of the Cardiovascular Research Foundation and as Chairman or board member of multiple medical devices and hospital systems as well as civic organizations.

  • 4031fadf 6917 4d3c 8bf8 6c44edf73d1a
    MD, FACC, Medical Advisor

    While maintaining his full medical and academic responsibilities at the Temple University and Hospital systems, provides the ex-officio Chief Medical Officer role for the company. Dr. Bashir shares the product design responsibilities with Mr. Green and leads the pre-clinical testing, regulatory and clinical plans.

  • 8adffdca 37be 4695 b8e6 0e0d697ef581
    Director Research & Development

    Leads the technical design implementation process. Nick brings extensive experience in the cardiovascular catheter field, including the Johnson & Johnson, Cordis franchise in the stent and related devices fields.

  • 0e78f3ef 3201 406b 95cc f56b9c55196e
    MD, PhD, FACC, Chief Scientific Officer

    a cardiologist, leads the regulatory, clinical, and reimbursement activities. He previously served as the Chief Scientific Officer of J&J Interventional Systems, Inc. under Marvin Woodall, and subsequently as Vice President of Research and Development, Clinical Research, and Health Economics and Reimbursement, successively, at Johnson & Johnson’s Cordis franchise.